topicPomegranate Extract Blood Pressure Meta-Analysis
claimBackground : Emerging evidence suggests that polyphenols may contribute to the attenuation of telomere attrition and the upregulation of insulin-like growth factor 1 (IGF-1), primarily in animal and cell studies, and to a lesser extent in humans.
evidence level2
citationFarhat G (2025)
sourceEffects of Pomegranate Extract on IGF-1 Levels and Telomere Length in Older Adults (55-70 Years): Findings from a Randomised Double-Blinded Controlled Trial.
topicPomegranate Extract Blood Pressure Meta-Analysis
claimPomegranate extract, known for its high antioxidant capacity, has shown promise in preventing telomere shortening and enhancing IGF-1 levels, but evidence in humans is lacking.
evidence level2
citationFarhat G (2025)
sourceEffects of Pomegranate Extract on IGF-1 Levels and Telomere Length in Older Adults (55-70 Years): Findings from a Randomised Double-Blinded Controlled Trial.
topicPomegranate Extract Blood Pressure Meta-Analysis
claimConclusions : Pomegranate extract significantly increased IGF-1 levels and could exert a positive role on vascular ageing.
evidence level2
citationFarhat G (2025)
sourceEffects of Pomegranate Extract on IGF-1 Levels and Telomere Length in Older Adults (55-70 Years): Findings from a Randomised Double-Blinded Controlled Trial.
topicPomegranate Extract Blood Pressure Meta-Analysis
claimBackground : Chronic inflammation increases morbidity in older adults and significantly impacts healthy ageing.
evidence level2
citationFarhat G (2025)
sourceEffects of Pomegranate Extract on Inflammatory Markers and Cardiometabolic Risk Factors in Adults Aged 55-70 Years: A Randomised Controlled Parallel Trial.
topicPomegranate Extract Blood Pressure Meta-Analysis
claimPomegranate extract (PE), rich in polyphenols, has been suggested to reduce inflammation and could prevent cardiovascular disease.
evidence level2
citationFarhat G (2025)
sourceEffects of Pomegranate Extract on Inflammatory Markers and Cardiometabolic Risk Factors in Adults Aged 55-70 Years: A Randomised Controlled Parallel Trial.